Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists
✍ Scribed by Karina L. Bienfait; Matthew Menza; Margery H. Mark; Roseanne D. Dobkin
- Book ID
- 116675356
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 111 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0967-5868
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors
## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin
## Abstract Valvular heart disease in patients being treated with ergot‐derivative dopamine agonists (Ergot‐DA) for Parkinson's disease has been reported to occur as a consequence of serotonine receptor stimulation. Goal of this analysis was to estimate the incidence of those changes from recently